Statistics
Publications
3
Citations
237
H-Index
3
Active since
2009
Affiliations
ME Bradley is an author at Novartis (United Kingdom) specializing in receptor-ligand interactions, ligand binding, and pharmacology.
Publications per year
2009–2014
3
3
SB265610 is an allosteric, inverse agonist at the human CXCR2 receptor
ME Bradley, ME Bond, Jodie Manini et al. · British Journal of Pharmacology · 2009 · 57 citations · Full text
1–3 of 3